ArticleFrontiers in oncology2014

miR-21 Expression in Cancer Cells may Not Predict Resistance to Adjuvant Trastuzumab in Primary Breast Cancer.

Boye Schnack Nielsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.